{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:53:43Z","timestamp":1785214423629,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.apsb.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T07:12:23Z","timestamp":1686640343000},"page":"392-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Visualization of nasal powder distribution using biomimetic human nasal cavity model"],"prefix":"10.1016","volume":"14","author":[{"given":"Jiawen","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-4644","authenticated-orcid":false,"given":"Huipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-0052","authenticated-orcid":false,"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib2","first-page":"333","article-title":"A review on intranasal drug delivery system","volume":"3","author":"Appasaheb","year":"2013","journal-title":"J Adv Pharm Educ Res"},{"key":"10.1016\/j.apsb.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.apsb.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10717540500309040","article-title":"Nasal delivery of insulin using bioadhesive chitosan gels","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2012.11.015","article-title":"Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation","volume":"166","author":"Thomann-Harwood","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","article-title":"Intranasal immunization with dry powder vaccines","volume":"122","author":"Bahamondez-Canas","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"Van Woensel","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","article-title":"Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis","volume":"295","author":"Costa","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in\u00a0vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3390\/jcm10112468","article-title":"Nasal delivery of acute medications for migraine: the upper versus lower nasal space","volume":"10","author":"Martin","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.2147\/IJN.S120939","article-title":"Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment","volume":"11","author":"Bi","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJN.S151475","article-title":"Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS\/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects","volume":"13","author":"Yan","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2023.06.007_bib16","first-page":"454","article-title":"Nasal drug delivery system-an overview","volume":"1","author":"Alagusundaram","year":"2010","journal-title":"Int J Res Pharm Sci"},{"key":"10.1016\/j.apsb.2023.06.007_bib17","first-page":"2997","article-title":"Nasal drug delivery systems: an overview","volume":"96","author":"Ghori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2023.06.007_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ejpb.2007.08.013","article-title":"Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats","volume":"68","author":"Chen","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/02652048.2011.630106","article-title":"Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan","volume":"29","author":"Pardeshi","year":"2012","journal-title":"J Microencapsul"},{"key":"10.1016\/j.apsb.2023.06.007_bib20","first-page":"5","article-title":"Nasal formulations for drug administration and characterization of nasal preparations in drug delivery","volume":"11","author":"Scherlie","year":"2020","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","article-title":"Nasal drug delivery\u2014recent developments and future prospects","volume":"161","author":"Illum","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","article-title":"How to characterize a nasal product. The state of the art of in-vitro and ex-vivo specific methods","volume":"561","author":"Salade","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Delivery Transl Res"},{"key":"10.1016\/j.apsb.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Mayank","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.apsb.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-009-0002-4","article-title":"Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method","volume":"27","author":"Kundoor","year":"2010","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","article-title":"Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast","volume":"28","author":"Kundoor","year":"2011","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2023.06.007_bib27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.xphs.2015.12.016","article-title":"Development and evaluation of a novel intranasal spray for the delivery of amantadine","volume":"105","author":"Lungare","year":"2016","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2019.04.030","article-title":"Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide","volume":"564","author":"Hu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119649","article-title":"Paeonol loaded cyclodextrin metal-organic framework particles for treatment of acute lung injury via inhalation","volume":"587","author":"Li","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib30","first-page":"823","article-title":"Advances in medical image three-dimensional reconstruction system","volume":"39","author":"Fang","year":"2022","journal-title":"Chin J Med Phys"},{"key":"10.1016\/j.apsb.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2016.09.029","article-title":"Optimized synthesis and crystalline stability of \u03b3-cyclodextrin metal-organic frameworks for drug adsorption","volume":"514","author":"Liu","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2018.09.003","article-title":"Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.06.007_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2008.11.009","article-title":"Development and testing of particulate formulations for the nasal delivery of antibodies","volume":"135","author":"Kaye","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2023.06.007_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.resp.2010.09.008","article-title":"Evaluation and comparison of nasal airway flow patterns among three subjects from Caucasian, Chinese and Indian ethnic groups using computational fluid dynamics simulation","volume":"175","author":"Zhu","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.apsb.2023.06.007_bib35","first-page":"814","article-title":"Nasal cavity computer fluid dynamics analysis on 60 healthy Chinese adults","volume":"48","author":"Zang","year":"2013","journal-title":"Chin J Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.apsb.2023.06.007_bib36","doi-asserted-by":"crossref","first-page":"121054","DOI":"10.1016\/j.ijpharm.2021.121054","article-title":"The effect of ingredients commonly used in nasal and inhaled solutions on the secretion of mucus","volume":"608","author":"Ayoub","year":"2021","journal-title":"in\u00a0vitro. Int J Pharm"},{"key":"10.1016\/j.apsb.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.surfin.2022.102460","article-title":"Highly reliable transparent superhydrophobic composite\u00a0by organosilane\/denture base resin-modified alkylated silica nanoparticles against contaminants","volume":"35","author":"Liu","year":"2022","journal-title":"Surface Interfac"},{"key":"10.1016\/j.apsb.2023.06.007_bib38","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.apsb.2021.03.019","article-title":"Metal-organic frameworks for advanced drug delivery","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"118911","DOI":"10.1016\/j.ijpharm.2019.118911","article-title":"Impact of physicochemical properties of nasal spray products on drug deposition and transport in the pediatric nasal cavity model","volume":"574","author":"Sosnowski","year":"2020","journal-title":"Int J Pharm"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523002101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523002101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:00:10Z","timestamp":1720594810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383523002101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2211383523002101"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2023.06.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visualization of nasal powder distribution using biomimetic human nasal cavity model","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}